FDA Approves Baxter's RIXUBIS For Treatment Of Children With Hemophilia B

By: via Benzinga
Baxter International Inc. (NYSE: BAX) today announced that the United States Food and Drug Administration (FDA) has approved RIXUBIS ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.